An audit of influenza vaccination status in adults with inflammatory bowel disease

Canadian Journal of Gastroenterology

Volumn 26, Issue 9, 2012, Pages 593-596

  Narula, Neeraj ^a   Dhillon, Amit S ^a   Chauhan, Usha ^a   Marshall, John K ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Crohn disease; Immunization; Inflammatory bowel disease; Influenza; Ulcerative colitis; Vaccination

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGED; ARTICLE; COMORBIDITY; CORRELATION ANALYSIS; ENTERITIS; FEAR; FEMALE; HUMAN; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; PRIORITY JOURNAL; SEASONAL INFLUENZA; VACCINATION REACTION;

EID: 84866762559     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2012/158362     Document Type: Article

References (27)

1. Thompson W, Shay D, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-86. (Pubitemid 36068705)
2. Fiore A, Shay D, Broker K, et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008;57:1-60.
3. Public Health Agency of Canada. Influenza (October 28, 2010) 〈www.phac-aspc.gc.ca/influenza/index-eng.php〉 (Accessed December 20, 2010).
4. Kangro H, Chong S, Hardiman A, et al. A prospective study of viral and mycoplasma infections in chronic inflammatory bowel disease. Gastroenterology 1990;98:549-53. (Pubitemid 20069688)
5. Harper S, Fukuda K, Uyeki T, et al. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2004;53:1-40.
6. Sands B, Cuffari C, Katz J, et al. Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis 2004;10:677-92. (Pubitemid 39276481)
7. Public Health Agency of Canada. Statement on Seasonal Trivalent Inactivated Influenza Vaccine (TIV) for 2010-2011 (August 6, 2010) 〈www.phac-aspc.gc.ca/publicat/ccdr-rmtc/10vol36/acs-6/index-eng.php〉 (Accessed December 20, 2010).
8. Rahier J, Ben-Horin S, Chowen Y, et al. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. JCC 2009;3:47-91.
9. Narula N, Yamamura D, Marshall J. Should my patient with inflammatory bowel disease on immunosuppressive therapy be vaccinated against influenza virus? Can J Gastroenterol 2010;24:121-5.
10. Melmed G, Ippoliti A, Papadakis K, et al. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol 2006;101:1834-40. (Pubitemid 44166594)
11. Sowden E, Mitchell W. An audit of influenza and pneumococcal vaccination in rheumatology outpatients. BMC Musculoskelet Disor 2007;8:58.
12. Bridges M, Coady D, Kelly C, et al. Factors influencing uptake of influenza vaccination in patients with rheumatoid arthritis. Ann Rheum Dis 2003;62:685. (Pubitemid 36760575)
13. Bridges C, Thompson W, Meltzer M, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA 2000;284:1655-63.
14. Fiore A, Bridges C, Cox N. Seasonal influenza vaccines. Curr Top Microbiol Immunol 2009;333:43-82.
15. Rahier J, Papay P, Salleron J, et al. H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy. Gut 2011;60:456-62.
16. Holvast B, Huckriede A, Kallenberg C, et al. Influenza vaccination in systemic lupus erythematosus: Safe and protective! Autoimmun Rev 2007;6:300-5. (Pubitemid 46507990)
17. Kwan O, Park Y, Choi J, et al. A case of ulcerative colitis relapsed by influenza vaccination. Korean J Gastroenterol 2007;49:327-30.
18. Fields S, Baiocco P, Korelitz B. Influenza vaccinations: Should they really be encouraged for IBD patients being treated with immunosuppressives? Inflamm Bowel Dis 2009;15:649-51.
19. Lu Y, Jacobson D, Ashworth L, et al. Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol 2009;104:444-53.
20. Mamula P, Markowitz J, Piccoli D, et al. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2007;5:851-6. (Pubitemid 47031059)
21. Elkayam O. Safety and efficacy of vaccination against influenza in patients with rheumatoid arthritis. Clin Dev Immunol 2006;13:349-51. (Pubitemid 44950050)
22. Oren S, Mandelboim M, Braun-Moscovici Y, et al. Vaccination against influenza in rheumatoid arthritis patients: The effect of rituximab on the humoral response. Ann Rheum Dis 2008;67:937-41. (Pubitemid 351956654)
23. Salemi S, Picchianti-Diamanti A, Germano V, et al. Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNF alpha blockers: Safety and immunogenicity. Clin Immunol 2010;134:113-20.
24. Candon S, Thervet E, Lebon P, et al. Humoral and cellular immune responses after influenza vaccination in kidney transplant recipients. Am J Transplant 2009;9:2346-54.
25. Kobashigawa J, Warner-Stevenson L, Johnson B, et al. Influenza vaccine does not cause rejection after cardiac transplantation. Transplant Proc 1993;25:2738-9. (Pubitemid 23239616)
26. Mauch T, Crouch N, Freese D, et al. Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus. J Pediatr 1995;127:957-60. (Pubitemid 26003292)
27. Ontario Ministry of Health and Long-Term Care. Guide to Physician Compensation. (September 2009) 〈www.health.gov.on.ca/transformation/fht/ guides/fht-compensation.pdf〉 (Accessed December 20, 2010).